WallStreetZenWallStreetZen

NYSE: ZBH
Zimmer Biomet Holdings Inc Stock

Overview
ForecastEarningsDividendOwnership
$119.43+0.10 (+0.08%)
Updated Apr 19, 2024
ZBH Price
$119.43
Fair Value Price
N/A
Market Cap
$24.49B
52 Week Low
$102.00
52 Week High
$149.25
P/E
24.32x
P/B
1.96x
P/S
3.44x
PEG
1.07x
Dividend Yield
0.8%
Revenue
$7.39B
Earnings
$1.02B
Gross Margin
71.8%
Operating Margin
17.14%
Profit Margin
13.8%
Debt to Equity
0.72
Operating Cash Flow
$2B
Beta
0.89
Next Earnings
May 2, 2024
Ex-Dividend
Mar 27, 2024
Next Dividend
Apr 30, 2024

ZBH Overview

Zimmer Biomet Holdings Incorporated operates in the musculoskeletal healthcare sector in the U.S. and internationally. The company offers orthopaedic reconstructive products for knees and hips, as well as sports medicine, biologics, foot and ankle, extremities, and trauma products. Other offerings include spine (devices and surgical instruments) and face and skull reconstruction products.The company was known as Zimmer Holdings, Inc. until 2015/06. Zimmer Biomet was founded in 1927 and is headquartered in Warsaw, IN.

Zen Score

–
Industry Average (27)
You've viewed Zen Score for 10/10 free stocks. Upgrade to Premium to see how ZBH scored across 38 valuation, financial, forecast, performance, and dividend due diligence checks.

Due Diligence Checks

ZBH ($119.43) is trading above its intrinsic value of $65.96, according to an updated version of Benjamin Graham's Formula from Chapter 11 of "The Intelligent Investor"
Below Benjamin Graham Formula Value Valuation
ZBH is good value based on its earnings relative to its share price (24.32x), compared to the US market average (40.51x)
P/E vs Market Valuation
ZBH is good value based... subscribe to Premium to read more.
P/E vs Industry Valuation
There are 35 more ZBH due diligence checks available for Premium users.

Be the first to know about important ZBH news, forecast changes, insider trades & much more!

ZBH News

Valuation

ZBH price to earnings (PE)

For valuing profitable companies with steady earnings
Company
24.32x
Industry
28.69x
Market
40.51x
ZBH is good value based... subscribe to Premium to read more.
P/E vs Industry Valuation
ZBH is good value based... subscribe to Premium to read more.
P/E vs Market Valuation

ZBH price to book (PB)

For valuing companies that are loss-making or have lots of physical asset
Company
1.96x
Industry
3.63x
ZBH is good value based... subscribe to Premium to read more.
P/B vs Industry Valuation

ZBH price to earnings growth (PEG)

For valuing profitable companies with growth potential
ZBH is poor value relative... subscribe to Premium to read more.
PEG Value Valuation

ZBH's financial health

Profit margin

Revenue
$1.9B
Net Income
$419.2M
Profit Margin
21.6%
ZBH's Earnings (EBIT) of $1.27B... subscribe to Premium to read more.
Interest Coverage Financials
ZBH's profit margin has increased... subscribe to Premium to read more.
Profit Margin Growth Financials

Assets to liabilities

Assets
$21.5B
Liabilities
$9.0B
Debt to equity
0.72
ZBH's short-term assets ($4.61B) exceed... subscribe to Premium to read more.
Short-term Liabilities Financials
ZBH's long-term liabilities ($6.15B) exceed... subscribe to Premium to read more.
Long-term Liabilities Financials
ZBH's debt relative to shareholder... subscribe to Premium to read more.
Shrinking Debt Financials
ZBH's debt to equity ratio... subscribe to Premium to read more.
Healthy Debt to Equity Financials

Cash flow

Operating
$588.4M
Investing
-$220.8M
Financing
-$251.4M
ZBH's operating cash flow ($1.58B)... subscribe to Premium to read more.
Debt Coverage Financials

ZBH vs Medical Device Stocks

TickerMarket Cap1d %P/EP/B
ZBH$24.49B+0.08%24.32x1.96x
ALGN$22.45B-0.78%51.37x6.19x
STE$19.71B-0.65%34.94x3.07x
PHG$18.11B0.00%-36.46x1.40x
SWAV$12.30B+0.45%82.04x18.40x
View Top Medical Device Stocks

Zimmer Biomet Holdings Stock FAQ

What is Zimmer Biomet Holdings's quote symbol?

(NYSE: ZBH) Zimmer Biomet Holdings trades on the NYSE under the ticker symbol ZBH. Zimmer Biomet Holdings stock quotes can also be displayed as NYSE: ZBH.

If you're new to stock investing, here's how to buy Zimmer Biomet Holdings stock.

What is the 52 week high and low for Zimmer Biomet Holdings (NYSE: ZBH)?

(NYSE: ZBH) Zimmer Biomet Holdings's 52-week high was $149.25, and its 52-week low was $102.00. It is currently -19.98% from its 52-week high and 17.09% from its 52-week low.

How much is Zimmer Biomet Holdings stock worth today?

(NYSE: ZBH) Zimmer Biomet Holdings currently has 205,084,022 outstanding shares. With Zimmer Biomet Holdings stock trading at $119.43 per share, the total value of Zimmer Biomet Holdings stock (market capitalization) is $24.49B.

Zimmer Biomet Holdings stock was originally listed at a price of $29.76 in Jul 25, 2001. If you had invested in Zimmer Biomet Holdings stock at $29.76, your return over the last 22 years would have been 301.31%, for an annualized return of 6.52% (not including any dividends or dividend reinvestments).

How much is Zimmer Biomet Holdings's stock price per share?

(NYSE: ZBH) Zimmer Biomet Holdings stock price per share is $119.43 today (as of Apr 19, 2024).

What is Zimmer Biomet Holdings's Market Cap?

(NYSE: ZBH) Zimmer Biomet Holdings's market cap is $24.49B, as of Apr 20, 2024.

Market cap (market capitalization) is the total market value of a publicly traded company's outstanding shares.

Zimmer Biomet Holdings's market cap is calculated by multiplying ZBH's current stock price of $119.43 by ZBH's total outstanding shares of 205,084,022.
©2024 WallStreetZen
Company
AboutNewsBlogStock Investing FAQPlansPrivacy PolicyTerms of ServiceCancellation & RefundsHelp GuidesContactTwitterYouTubeNewsletter
Stock Tools
Top Performing AnalystsStock ScreenerStock ForecastTrending StocksStrong Buy StocksHighest Earnings StocksBest Dividend Paying StocksStatisticsStock Market SectorsStock Market IndustriesHow to Buy Stocks Online
Stock Ideas
Buy The DipBiggest Stock Gainers TodayBiggest Stock Losers Today52 Week High Stocks52 Week Low StocksMost Active Stocks TodayMost Undervalued StocksBest Penny Stocks to Buy NowBest Stocks Under $5Best Stocks Under $10
WallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.

Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.